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Abstract
Background: While adverse effects of exposure to air pollutants on respiratory health are well studied, little is
known about the effect of a reduction in air pollutants on chronic respiratory symptoms and diseases. We
investigated whether different declines in air pollution levels in industrialised and rural areas in Germany were
associated with changes in respiratory health over a period of about 20 years.
Methods: We used data from the SALIA cohort study in Germany (Study on the influence of Air pollution on Lung
function, Inflammation and Aging) to assess the association between the prevalence of chronic obstructive
pulmonary disease (COPD) and chronic respiratory symptoms and the decline in air pollution exposure. In 1985-
1994, 4874 women aged 55-years took part in the baseline investigation. Of these, 2116 participated in a
questionnaire follow-up in 2006 and in a subgroup of 402 women lung function was tested in 2008-2009.
Generalized estimating equation (GEE) models were used to estimate the effect of a reduction in air pollution on
respiratory symptoms and diseases.
Results: Ambient air concentrations of particulate matter with aerodynamic size < 10 μm (PM10) declined in
average by 20 μg/m
3. Prevalence of chronic cough with phlegm production and mild COPD at baseline
investigation compared to follow-up was 9.5% vs. 13.3% and 8.6% vs. 18.2%, respectively. A steeper decline of PM10
was observed in the industrialized areas in comparison to the rural area, this was associated with a weaker increase
in prevalence of respiratory symptoms and COPD. Among women who never smoked, the prevalence of chronic
cough with phlegm and mild COPD was estimated at 21.4% and 39.5%, respectively, if no air pollution reduction
was assumed, and at 13.3% and 17.5%, respectively, if air pollution reduction was assumed.
Conclusion: We concluded that parallel to the decline of ambient air pollution over the last 20 years in the Ruhr
area the age-related increase in chronic respiratory diseases and symptoms appears to attenuate in the population
of elderly women.
Introduction
Several epidemiological studies have shown that chronic
exposure to high levels of air pollutants (PM10 and
NO2) has adverse effects on respiratory health. These
adverse effects on respiratory health are not limited to
high concentrations of air pollutants, but have also been
observed at relatively low concentrations. It has been
previously reported that long-term exposure to air pol-
lutants from traffic related sources reduce lung function
[1-5] and influence chronic respiratory diseases [6-8].
Furthermore, long-term exposure to air pollutants is
known to be associated with cardiovascular mortality
[9-12] and increased hospital admissions [13-16].
However, less is known about the effect of a reduction
in air pollutants on chronic respiratory symptoms and
diseases, including chronic cough. Chronic cough is
common in people aged 70 and over and the prevalence
increases further with age [17-21]. Additionally, chronic
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ment of chronic obstructive pulmonary disease [21,22].
T h e r ei se v i d e n c et h a tar e d u c t i o ni na i rp o l l u t a n t s
attenuates the decline in respiratory health in children.
The delay in lung function development, due to air pol-
lutants, attenuates when the children move to cleaner
areas [23,24]. Moreover, a recent prospective cohort
study of adults living in Switzerland, the Swiss study on
Air Pollution and Lung Disease in Adults (SAPALDIA),
showed that a decline in lung function [25], as well as
an increase of respiratory symptoms [26], is attenuated
by a reduction in exposure to PM10. However, the effect
of a reduction in air pollutants on respiratory health in
elderly people has not been analysed so far.
In the present study, we investigated whether the age-
related increase of respiratory symptoms and diseases is
attenuated by a reduction in exposure to ambient air
pollutants using data collected from the SALIA study
(the Study on the influence of Air pollution on Lung
function, Inflammation and Aging), a prospective cohort
of elderly women living in the highly industrialised Ruhr
district and in adjacent rural areas in Germany. Chronic
respiratory symptoms and lung function were first mea-
sured in 1985-1994, when ambient air pollution expo-
sure was high, and follow-up was conducted from 2006
to 2009, when concentrations of ambient air pollutants
in the Ruhr district had been considerably reduced.
Thus, we were provided with sufficient power to exam-
ine whether the changes in prevalence of respiratory
symptoms and disease were attenuated by reduction in
ambient air pollutants.
Materials and methods
Design and study population
The SALIA study was initiated in the early 1980 s by
the North Rhine-Westphalia State Government to inves-
tigate the effect of air pollution exposure in women.
The study population was a sample of women from the
Ruhr area, Germany, and two rural areas in the North
of the Ruhr area. Health examinations were conducted
between 1985 and 1994 in 4874 women, who were all
approximately 55-years of age at the time of examina-
tion. Health examinations included lung function mea-
surements for a subset of the participants (n = 2,593).
Previous results of the baseline investigation showed
that exposure to high concentrations of air pollutants
reduces lung function and was associated with COPD
[6,10]. In 2006, a follow-up study of the same women
was conducted to assess the changes in respiratory
symptoms and diseases in these women after a strong
decline in concentrations of ambient air pollutants in
the Ruhr area. A questionnaire about respiratory health
and its risk factors was sent out to all surviving partici-
pants, each of whom received three reminder letters.
Completed questionnaires were received from 2116
(53%) of the surviving participants. In 2007 to 2009 a
follow-up examination in a subgroup of the study popu-
lation was conducted. This subgroup consisted of 706
women who had a lung function measurement at base-
line and who agreed to further examinations in the
questionnaire follow-up in 2006. The women were
invited in a randomized manner from four cities in the
Ruhr area (Duisburg, Dortmund, Essen and Gelsen-
kirchen), as well as the rural county of Borken, which
was used as a reference area. In total, 402 women, who
were aged 70 to 80 years old, participated and lung
function testing was completed in 395 of these partici-
pants. Figure 1 gives a flow chart of the SALIA cohort
study between baseline investigation and follow-up. The
present analysis was restricted to the women who had
complete information on respiratory health outcomes at
baseline investigation and at the follow-up. Approval of
the study was obtained from the Ethical Committee of
the University of Bochum. We received written
informed consent from all participants.
Assessment of respiratory health and risk factors by
questionnaire
Together with an invitation to participate in the baseline
investigation, the women received a self-administered
questionnaire about respiratory health and its risk fac-
tors. The same questions regarding respiratory symptoms
and diseases of the baseline investigation were used in
the follow-up. We asked whether a physician had ever
diagnosed chronic bronchitis and additionally we asked
for respiratory symptoms. Respiratory symptoms were
divided in two categories: “frequent cough in the morn-
ing or during the day a) without phlegm production or b)
with phlegm production”. We additionally collected
information about the following known risk factors for
respiratory diseases in the questionnaire: current and
past smoking habits, passive smoking exposure at home
or at work, indoor exposure by heating with fossil fuels,
and occupational exposures to dust or fumes. For smok-
ing habits, the women were grouped as never smoker,
passive smoker (at home or/and at work place), past
smoker or current smoker. We classified socioeconomic
status at baseline into four categories using the highest
school level achieved by either the women or her hus-
bands as low (< 10 years), medium (= 10 years) or med-
ium high (11-12 years) and high >12 years).
Lung function measurement and COPD definition
Spirometry was performed according to the ATS/ETS
recommendations [25]. Forced expiratory volume in 1
second (FEV1) and forced vital capacity (FVC) were
measured. Between three to four manoeuvres were per-
formed under direction of trained personnel, and the
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All measuring instruments were calibrated prior to each
testing. The technical personnel were trained and all
results were reviewed by a pulmonary physician. COPD
was defined using the ratio FEV1/FVC, which is consid-
ered a sensitive measure of COPD on its own [26]. We
defined two forms of COPD: mild COPD (stage 1) was
defined as FEV1/FVC ratio < 0.7 and the moderate form
(stage 2) as FEV1/FVC ratio <0.7 and FEV1 <8 0 %o f
predicted value. Both constitute the main criterion for
COPD according to the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) criteria [27]. How-
ever, we used a modified version of the GOLD criteria
as we did not use post-bronchodilator measurements in
our analysis. We therefore excluded women who
reported asthma from the analysis, in which COPD
was the outcome, to avoid confounding. Asthma was
considered present when ever diagnosed by a physician
(Table 1). We additionally conducted a sensitivity analy-
sis including women with asthma.
Air pollution measurements
In the assessment of air pollution, we used data from
local monitoring stations maintained by the State Envir-
onmental Agency of North Rhine-Westphalia since
more than 25 years. These monitoring stations are
designed to reflect broad scale spatial variations in air
quality. All monitoring stations used in this study were
located within a distance of not more than 8 km to the
women’sh o m ea d d r e s s .T h ei n d i v i d u a le x p o s u r et o
background ambient air pollution at baseline and fol-
low-up investigation was estimated by the PM10 and
NO2 concentrations of the monitoring station located
nearest to the participant’s residential address. To assess
long-term exposure, we used the 5-year mean concen-
trations of PM10 and NO2. For characterizing long-term
exposure at baseline, we used the five year mean of the
year of the baseline examination (within 1985 to 1994)
and the preceding four years and, for exposure at fol-
low-up, the means of the years 2002 to 2006. Due to the
incompleteness of air pollution data from Borken, where
continuous measurements only started in 1990, moni-
toring data proceeding this year were imputed by using
measurements from 1981 to 2000 from 15 monitoring
stations in the Ruhr area assuming similar trends. The
imputation was performed by using linear regression
modelling with air pollution as the depended variable,
year of measurement as the independent variable and an
autoregressive correlation between repeated measure-
ments performed at the same measurement site using
air pollution measurements from 1981 to 2000 [10].
Between 1985 and 1987, discontinuous measurements
were performed in Borken (four days per month), and
these agreed well with the imputed values [6].
Statistical analysis
The association between air pollution levels and the pre-
valence, and changes in prevalence, of COPD and
Figure 1 Flowchart showing the SALIA collective from baseline till follow-up in 2007/2008.
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analyzed using generalised estimating equations (GEE).
The individual change in exposure ΔE was calculated as
t h ed i f f e r e n c eb e t w e e nt h eb a s e l i n em e a s u r e m e n ta n d
the measurement at follow-up. For multivariate regres-
sion modelling, we assumed linear dependency of the
prevalence of chronic respiratory diseases and symptoms
on exposure at baseline (Ebaseline), and on the time of
follow-up t, since all women were 55 years of age at
baseline. Additionally, we investigated whether the age
related increase in diseases or symptoms associated with
the time of follow-up t was linearly modified by the
change in exposure ΔE.
The GEE model controlled for a set of potential con-
founder (smoking behaviour, passive smoking, social status
and exposure to indoor air pollutants) on an individual
basis. However inclusion of social status, indicated by
school education, passive smoking and indoor air pollution
exposure did not change the parameter estimates by more
than 10% and were not included in the final model.
The final models were written as follows:
pE S
pE
baseline baseline
tb a s e l i n e
001 4
01 2
=+ +
=+ + +
 
 
**
*(
 and
  34 5 *) * * * Et S S baseline follow up ++ −
with: p0 prevalence at baseline, pt prevalence at follow-
up, Ebaseline exposure at baseline, ΔE exposure decline
(exposure at baseline minus exposure at follow-up), t fol-
low-up time, Sbaseline smoking at baseline (yes = 1, no = 0)
and Sfollow-up smoking at follow-up (yes = 1, no = 0).
All statistical analyses were performed with SAS for
windows release 9.1 (SAS Institute, Cary, NC).
Results
Characteristics of study participants
The characteristics of the study cohort are presented in
Table 1. The majority of the study participants lived in
cities of the Ruhr area. The mean age of these women
at the follow-up investigation in 2006 was 71.3 years.
Little change in body mass index (BMI) was observed.
Most women tended to give up smoking; similarly, pas-
sive smoke exposure was considerably reduced between
baseline and follow-up investigation. A reduction of
heating with fossil fuels was reported throughout the
areas. The majority of women had a school education of
10 or more years. A slight increase in reported asthma
and a doubling of reported hypertension was observed
between the baseline investigation and the follow-up.
Twelve per cent of the women were occupationally
exposed to dust and fumes before baseline investigation,
but not afterwards. Occupational exposure to dust and
fumes was not considered as a potential risk factor in
the proceeding analysis. More than 98% of the partici-
pants had not moved since baseline. We also evaluated
whether participants from the 2006 survey differed from
non-participants. Length of education was a primary dif-
ferentiating factor; less than 10 years of schooling was
reported by 21.6% of those responding at baseline, by
38.5% of those 595 women who died between baseline
Table 1 Characteristics of the study population of elderly women at baseline and at follow-up
Baseline 1985-1994 Follow-up 2006 Follow-up 2007/2008
N Mean ±SD N Mean ±SD N Mean ±SD
Age (year) 2115 54.5 ± 0.7 2106 71.3 ± 3.3 402 74.1 ± 2.6
BMI (kg/m
2) 1874 27.2 ± 4.2 2048 27.0 ± 4.7 402 27.6 ± 4.6
N% N % N %
Urban residency
a 2116 55.7 2116 55.7 402 52.7
Smoking status:
Passive smoking 2091 47.1 2014 14.5 402 5.7
Ex smoker 1758 9.0 2063 14.6 402 15.7
Current smoker 2112 11.9 2063 5.6 402 3.0
Indoor exposure
b 2081 18.2 1809 12.6 402 12.9
Education: 2098 - 2098 - 402 -
< 10 years - 22.0 - 22.0 - 17.3
= 10 years - 48.9 - 48.9 - 51.0
11-12 years - 18.1 - 18.1 - 19.7
> 12 years - 11.0 - 11.0 - 12.2
Asthma 2074 2.0 2021 5.4 401 9.7
Hypertension 2077 23.3 1997 53.4 400 66.3
SD: Standard deviation
BMI: Body mass index (weight/height
2)
a Urban. Duisburg, Dortmund, Essen, Gelsenkirchen; rural: Borken
b Heating with fossil fuels (gas, coal or wood)
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ing but who were still alive. We additionally examined
whether the associations between air pollution and
respiratory health as reported in a previous publication
of the same cohort [28] differed between the responder
groups, but did not detect any systematic differences; no
significant interactions were observed between respon-
der status and air pollution on respiratory health.
Prevalence of respiratory health outcomes
The prevalence of chronic bronchitis, respiratory symp-
toms and COPD are shown in Table 2. The prevalence
of respiratory symptoms and chronic bronchitis by phy-
sician’s diagnosis increased between the baseline investi-
gation and 2006 with increasing age of the participants.
Participants who had missing answers in the question-
naire were excluded from the analysis, so the numbers
vary slightly from one respiratory health outcome to
another. Chronic cough was the most commonly
reported respiratory symptom with a prevalence of
20.6% and 26.5% at baseline and at follow-up, respec-
tively. The prevalence of mild COPD assessed with
FEV1/FVC < 0.7 at baseline was 8.6% and 18.2% at fol-
low-up and, therefore, comparable to the prevalence of
chronic cough with phlegm production. Only a few par-
ticipants were classified as having moderate COPD (n =
14 and n = 23, respectively). At the baseline investiga-
tion the prevalence of all respiratory symptoms and dis-
eases was lower in the rural than in the urban areas
whereas this was not true for the follow-up
investigation.
Change in concentrations of PM10 and NO2
A strong decrease in air pollution levels was observed
throughout the entire study area (Table 3). In particular,
urban areas with high PM10 levels at baseline experi-
enced a strong reduction in concentrations through to
follow-up (Figure 2). Across the 5 study areas, the
5-year mean PM10 concentrations declined on average
from 46.6 μgt o2 6 . 9μg (interquartile range: 10 μg/m
3).
A slightly weaker decline was observed for NO2 concen-
trations (Figure 3). In the rural area of Borken, NO2
concentrations remained stable during the 20 years of
the follow-up, but the 5-year mean concentrations of
NO2 decreased in average from 38.1 μg to 27.9 μg
(interquartile range: 12.2 μg/m
3).
Decline in air pollution exposure and change of
prevalence of respiratory health outcomes
The association of decline in PM10 and NO2 pollution
between baseline and follow-up with the prevalence of
respiratory symptoms and diseases at baseline and at
follow-up is presented in Table 4. The table shows the
mutually adjusted parameter estimates (prevalence
change per unit) for smoking at baseline, change in
Table 2 Prevalence of respiratory symptoms, chronic bronchitis at baseline (1985 - 1994) and at follow-up (2006) and
COPD at baseline (1985-1994) and at follow-up (2007/2008) in a subgroup of elderly women
Prevalence
Baseline Follow-up
Respiratory health outcome all Ruhr area rural areas all Ruhr area rural areas
Chronic Bronchitis by physician’s diagnosis
a N = 2073
(8.2%)
N = 1167
(9.3%)
N = 905
(6.6%)
N = 2032
(11.6%)
N = 1125
(13.6%)
N = 90782
(9.0%)
Chronic cough
a N = 2110
(20.6%)
N = 1175
(22.7%)
N = 935
(18.0%)
N = 1947
(26.5)
N = 1079
(27.9%)
N = 868
(24.7%)
Chronic cough with phlegm production
a N = 2099
(9.5%)
N = 1168
10.1%
N = 931
8,8%
N = 1979
(13.3%)
N = 1098
(13.5%)
N = 890
(13.2%)
Mild COPD
b FEV1/FVC < 0.7 N = 384
(8.6%)
N = 201
10.5%
N = 183
6.6%
N = 347
(18.2%)
N = 179
(12.9%)
N = 163
(22.7%)
Moderate COPD
bFEV1/FVC< 0.7 and FEV1< 80% predicted N = 384
(3.7%)
N = 201
5.0%
N = 183
2.2%
N = 347
(6.6%)
N = 179
(5.6%)
N = 163
(8.0%)
aReported by participant
bOnly in a subgroup that was invited for the follow-up examination in 2007/2008. Women with asthma were excluded
Table 3 Distribution of long-term air pollution exposures
among women living in the Ruhr area and an adjacent
rural area in Germany at baseline and at follow-up
Total Group (n = 2116)
Baseline
in
1985-1994
Follow-up
in
2006
Change in
rural area
Change in
urban area
PM10 No2 PM10 NO2 PM10 NO2 PM10 NO2
Min 38.9 22.0 25.0 20.2 13.9 1.8 14.8 8.6
25 Percentile 42.6 24.4 25.0 20.2 14.3 2.6 16.2 13.4
Median 46.9 39.8 26.0 31.2 14.3 4.2 23.1 16.4
Mean 46.6 38.1 26.9 27.9 17.6 3.8 21.4 15.4
75 Percentile 52.1 49.8 28.4 32.8 21.9 4.8 24.6 17.2
Max 53.6 61.0 30. 5 44.6 24.0 6.3 25.2 21.2
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Figure 3 Annual mean concentrations of nitrogen dioxide (NO2) from 1982 to 2008 by study area.
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Page 6 of 11smoking behaviour between baseline and follow-up,
baseline exposure, follow-up time and finally for the
change in exposure between baseline and follow-up.
The prevalence of respiratory health outcomes
increased with increasing age of the cohort. Exposure to
ambient air pollution at baseline was also an important
risk factor for respiratory health. However, with the
exception of chronic bronchitis, the increase in preva-
lence of cough, without and with phlegm production, as
well as of mild and moderate COPD were significantly
(p < 0.05) attenuated by the decline of background con-
centration of PM10 in ambient air (for moderate COPD
p<0 . 0 9 ) .F o ra no b s e r v e dd e c l i n eo fN O 2 background
concentration in ambient air by approximately
10 μg/m
3, the respective effect on the respiratory health
outcomes was only marginal. Smoking at baseline was a
strong risk factor for chronic cough with and without
phlegm production, but quitting smoking between base-
line and follow-up significantly reduced the prevalence
of these respiratory symptoms. A decrease in PM10 by
20 μg/m
3 over a period of 10 years of follow-up attenu-
ated the prevalence of the age-related increase of
chronic cough with and without phlegm production, as
well as mild COPD.
Industrialized and rural areas might differ in some
respects, which we did not account for in our analysis.
Therefore as a sensitivity analysis we repeated the analy-
sis only including women from urban areas (data not
shown). The parameter estimates for prevalence of
cough, with and without phlegm production, were simi-
lar but less significant. Chronic bronchitis now showed
a reduction in prevalence due to the decline in both the
exposures of PM10 (p < 0.270) and in NO2 (p < 0.049).
All other results remained unchanged.
In order to address whether potentially erroneous
assessing of smoking might have affected the results, we
additionally did all analysis only including non smoking
women into the analysis. The parameter estimates varied
in an unsystematic way. The effect for chronic cough
was slightly stronger, whereas the effect for COPD was
slightly weaker, the significance remained the same.
As a further sensitivity analysis we also repeated the
analysis for COPD as defined by lung function without
excluding women reporting asthma. All results were
slightly stronger (data not shown) and significance
remained.
Table 5 summarizes the comparison of the model esti-
mated and observed prevalence of respiratory symptoms
and COPD for participants who never smoked. We cal-
culated estimated prevalences using the model equations
g i v e ni np a r a g r a p h2 . 5‘Statistical analysis’ and the
results of GEE regression analysis given in table 4.
Table 4 Results of GEE regression analysis: Association of prevalence of chronic bronchitis, respiratory symptoms, and
COPD with smoking at baseline and at follow up, exposure at baseline, follow-up time and exposure decline;
coefficients are mutually adjusted
Chronic bronchitis
a
Chronic cough Chronic cough with
phlegm production
Mild COPD
b Moderate COPD
c
PM10 NO2 PM10 NO2 PM10 NO2 PM10 NO2 PM10 NO2
Sample size 1950 1902 1922 342 342
Parameter estimates and 95% confidence interval (times 100)
Intercept -1.51-
12.04;9.02
4.33
*0.94;7.73
0.24-
14.85;15.33
15.05
*10.15;19.95
5.10-
6.06;16.26
9.07
*5.48;12.67
-2.81-
28.64;23.01
3.93-
3.47;11.33
-15.52
*-24.83;-
6.21
0.15-
4.04;4.34
Smoking at baseline 2.42-
1.31;6.16
1.95-
1.66;5.57
13.94
*8.35;19.54
13.99
*8.36;19.62
5.92
*1.64;10.20
6.08
*1.77;10.39
3.92-
5.34;13.19
4.67-
4.95;14.28
7.02-
0.89;14.92
7.62-
1.01;16.24
Smokingat follow-up -1.20
-7.45;5.06
-1.57-
7.83;4.68;
14.59
*5.86;23.32
14.46 *
5.73;23.20
7.82 *
1.56;14.08
7.96
*1.83;14.09
-9.25-
27.72;9.22
-9.45-
27.38;8.48
–2.18-
16.06;11.69
2.04-
16.02;11.93
Exposure at baseline
d 2.01-
0.25;4.26
2.32
*0.18;4.47
4.04
*0.80;7.28
2.69-
0.40;5.77
0.82-
1.56;3.20
-0.07-
2.25;2.11
2.35-
3.24;7.94
2.97-
1.99;7.94
3.96
*1.60;6.32
2.05-
0.96;5.06
Follow up time
e 2.22-
2.24;6.69
1.82
*0.28;3.37
12.58
*5.80;19.36
5.37
*2.77;7.98
8.22
*3.07;13.37
3.60
*1.60;5.59
20.61
*7.81;33.41
9.12
*4.78;13.46
8.02
*0.01;16.03
2.73
*0.03;5.43
Follow up time
exposure decline
f
-0.17-
4.37;4.03
0.21-
1.08;1.50
-8.17
*-14.54;-
1.79
-1.15-
3.25;0.96
-5.39
*-10.22;-
0.57
-0.87-
2.41;0.66
-14.62
*-25.88;-
3.36
-4.64
*-8.03;-
1.26
-6.20-
13.33;0.94
-1.66-
3.8;0.048
*p < 0.05
a Reported physician’s diagnosis
b FEV1/FVC <0.7
c FEV1/FVC <0.7 and FEV1 < 80% predicted
d unit: PM10 10 μg/m
3,N O 2 25 μg/m
3
e unit: 10 yr
f unit: PM10 20 μg/m
3 /10 yr, NO2 10 μg/m
3 /10 yr
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follow-up were very similar. Furthermore, the GEE
model allowed for estimating the prevalence, if no expo-
sure decline would have occurred, and the estimated
prevalence of this counterfactual scenario demonstrated
an attributable effect of air pollution decline. For an
exposure decline of PM10 of 20 μg/m
3 within 15 years, a
hypothetical attenuation of the prevalence of respiratory
symptoms and COPD between 8% and 20% was esti-
mated, respectively. Among, women who never smoked,
the prevalence of chronic cough with phlegm produc-
tion and mild COPD was estimated at 21.4% and 39.5%,
respectively, if no ambient air PM10 reduction was
assumed. However, these estimates were changed to
13.3% and 17.5%, respectively, if air pollution reduction
as observed was assumed. For an exposure decline of
NO2 of 10 μg/m
3, the attributable effect was consider-
ably weaker compared to the corresponding decline of
PM10.
Discussion
Between 1985 and 2006 air pollution declined with most
pronounced changes in industrialized areas as compared
to the rural area. In the SALIA cohort we showed that
the extent of air pollution decline was associated with a
corresponding significant reduction of the age-related
increase in prevalence of respiratory symptoms and
COPD
Our findings are analogue with the results of the Swiss
Cohort Study on Air Pollution and Lung Diseases in
Adults (SAPALDIA) study in Switzerland, which
observed that decreasing exposure to airborne particles
attenuated the decline in lung function in that cohort
[29]. Another study of the same cohort also reported a
decline in PM10 exposure in association with a reduc-
tion in respiratory symptoms [30]. In the SAPALDIA
study population, whose average age of participants was
41.4 years, the estimated relative decrease of cases with
chronic cough for instance that could be attributed to a
mean decline of 6.2 μg/m
3 ambient PM10 over 10 years
w a s1 2 . 2 %[ 3 0 ] .C o m p a r e dt ot h i ss t u d y ,w ef o u n da
similar relative decrease of the prevalence of chronic
respiratory symptoms as well as respiratory diseases in
our cohort. The estimated relative decrease of cases
with chronic cough for instance that could be attributed
t oam e a nd e c l i n eo f2 0μg/m
3 PM10 was 31.6%, which
correspond to a decrease of 9.8% per decline of 6.2 μg/
m
3, assuming linearity of the association. Other studies
investigated the effect of declining air pollution in cross
sectional studies: Studies in children from East Germany
showed that the improvement of non-allergic respiratory
morbidity and lung function in children was associated
with declining levels of air pollution [31-33]. Mortality
studies showed a reduction in cardiovascular mortality
after a decline in ambient air pollution exposure [34].
The previously cited studies and the present one collec-
tively demonstrate a consistent pattern in which reduc-
tions in air pollution levels have a beneficial effect on
health.
One limitation of our study is our low rate of partici-
pation at follow-up relative to baseline for questionnaire
items (~50%) and lung function measurements (~15%).
Additionally, higher educated women participated more
often in the follow-up investigation, therefore, the
reported prevalence estimates may be affected by non-
responder bias. The main aim of our paper, however, is
not to give representative prevalence data, but to esti-
mate whether decline in pollution has a favourable effect
on increase of respiratory symptoms and diseases in the
elderly. We do not assume that this association may be
distorted by non-responder bias since the associations
between air pollutants and respiratory symptoms were
similar in responders and non responders.
We further assumed in our model that the effect of
current smoking was the same in the baseline and in
the follow-up investigation (regardless of cigarettes per
day or age). In order to address whether potentially
erroneous assessing of smoking might have affected the
Table 5 Comparison of models with estimated and
observed prevalence of respiratory symptoms and COPD
among female never smokers
Time Exposure Prevalence [%]
Model:
PM10
Model:
NO2
observed
Chronic cough
Baseline Median exposure
a 19.8 20.1 18.9
15 years
later
No exposure
decline
38.6 28.1 –
Exposure decline
b 26.4 26.4 26.5
Chronic cough with phlegm production
Baseline Median exposure
a 9.1 8.9 8.8
15 years
later
No exposure
decline
21.4 14.3 –
Exposure decline
b 13.3 13.0 13.3
Mild COPD
c
Baseline Median exposure
a 8.5 9.4 8.4
15 years
later
No exposure
decline
39.5 23.1 –
Exposure decline
b 17.5 16.1 18.2
Moderate COPD
d
Baseline Median exposure
a 3.6 4.0 3.2
15 years
later
No exposure
decline
15.6 8.1 –
Exposure decline
b 6.3 5.6 6.6
a Exposure at baseline (median) of PM10 and NO2: 48.3 mg/m
3 and 46.6 μg/m
3
b Exposure decline (average) of PM10 and NO2:2 0μg/m
3 and 10 μg/m
3
c FEV1 /FVC < 0.7
d FEV1 /FVC < 0.7 and FEV1 < 80% reference value
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non smoking women into the analysis. The results
hardly changed indicating that erroneous assessing of
smoking did not bias the effect estimate.
Exposure was characterized by five year concentration
means preceding the investigation. Like most other epi-
demiological studies about effects of long-term air pollu-
tion exposure we do not know whether lifetime
exposure of the women investigated or current exposure
(at the day of investigation) or interactions between
chronic and current exposures might modify our results.
The assessment of self-reported symptoms in epide-
miological studies is not free from measurement error
[35]. For longitudinal studies, specifically, measurement
error occurring at both baseline and follow-up may lead
to bias of reported incidence estimates [36]. Therefore,
we chose to report and model prevalence of respiratory
symptoms and diseases rather than the cumulative inci-
dence and remission rates.
The accuracy of self-reported chronic respiratory
symptoms and diseases in a questionnaire is difficult for
this age group, recall bias may occur and many of the
participants may not remember exactly what the doctor
had informed them. A study by Medbo et al. observed
that the reporting of cough, especially with phlegm pro-
duction, was lower in elderly females than in males, sug-
gesting that cough with phlegm production may not be
considered a feminine behaviour [21]. Our study popu-
lation, however, consisted of women only. We further
investigated persons living in urban and rural areas with
various levels of exposure. These study locations were
chosen to represent a large range of air pollution con-
centrations. It is possible that elderly women differ in
urban and rural areas not only in terms of air pollution
exposure, but also in terms of lifestyle and social status
factors associated with respiratory health. We included
social status as covariate in our analysis. Consistent with
previous studies in elderly female populations, we could
show that there was no strong association between
exposure to air pollutants and socioeconomic status
[10,37]. Furthermore, we only observed a marginal and
non significant association between respiratory health
outcomes and educational level.
Our analysis showed a slightly higher prevalence of
mild and moderate COPD in the rural areas compared
to women from the urban areas. However, in a previous
mortality analysis [10] we could observe a higher air
pollution-associated mortality in women from the urban
areas, therefore it is possible that women living in urban
areas with mild to moderate COPD are already passed
away and hence were lost at the follow-up.
We used pre-bronchodilator measurements to define
COPD in our study population, however the GOLD cri-
teria recommends post-bronchodilator measurements
for the assessment of COPD. We therefore excluded all
women who reported asthma at baseline and at the fol-
low-up from our analysis and used a modified version of
the GOLD criteria. However, since awareness of asthma
has increased during the last 20 years this procedure
might have introduced a bias. As a sensitivity analysis
we additionally estimated the effects of declining air pol-
lution on COPD without excluding asthma cases. The
effect estimates were bigger and the significance stron-
ger. Our results therefore might underestimate the true
effect. It is further possible that COPD in older women
is overestimated when using FEV1/FVC <0.7 for defini-
tion. We therefore additionally used moderate COPD
(FEV1/FVC <0.7 and FEV1 < 80% of the predicted) to
define ‘definite’ cases of COPD [38]. This cut off is con-
sidered to be more reliable than the GOLD criteria
when identifying incidence of COPD in elderly subjects
[39]. Irrespective whether FEV1/FVC <0.7 in older age
reflects a disease, an increase clearly reflects an aging of
the lung. Our previous study [6] showed that this lung
aging was accelerated in the highly polluted areas at
baseline. The results at follow up demonstrate that the
increase in lung aging in these areas was attenuated due
to a steep decline in air pollution exposure.
T oo u rk n o w l e d g e ,t h i si st h ef i r s tG e r m a nc o h o r t
study investigating the association between the decline
in air pollution and the prevalence of respiratory symp-
toms and diseases in women followed for more than
20 years. The primary strengths of our study are the
long follow-up period of approximately 20 years for
these women, and the objective exposure assessment.
Furthermore, 98% of the women did not move during
the follow-up period; the neighborhood effects for the
majority of the participants did not change.
Conclusion
Parallel to the decline of ambient air pollution over the
last 20 years in the Ruhr area a reduction of the preva-
lence of chronic respiratory diseases and symptoms
attributable to air pollutants in a study population of
elderly women could be observed. Our findings provide
support that the reduction in air pollution appears to
attenuate respiratory aging in these women.
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